Cargando…
53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil
Chemoresistance of breast cancer is a worldwide problem for breast cancer and the resistance to chemotherapeutic agents frequently led to the subsequent recurrence and metastasis. In our previous study, we have found that 53BP1 showed a gradual decrease during the progression of breast cancer and lo...
Autores principales: | Li, Xiaoyan, Kong, Xiaoli, Kong, Xiangnan, Wang, Yang, Yan, Shi, Yang, Qifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765449/ https://www.ncbi.nlm.nih.gov/pubmed/24040364 http://dx.doi.org/10.1371/journal.pone.0074928 |
Ejemplares similares
-
53BP1 suppresses epithelial–mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer
por: Kong, Xiangnan, et al.
Publicado: (2015) -
53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway
por: HONG, SHUHUI, et al.
Publicado: (2012) -
Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer
por: Wang, Haiji, et al.
Publicado: (2014) -
Correction: Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer
por: Wang, Haiji, et al.
Publicado: (2019) -
Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
por: Yi, Jianing, et al.
Publicado: (2020)